about
Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosisMonitoring CSF proteome alterations in amyotrophic lateral sclerosis: obstacles and perspectives in translating a novel marker panel to the clinicImproved bi-allelic modification of a transcriptionally silent locus in patient-derived iPSC by Cas9 nickaseInteraction of physical function, quality of life and depression in Amyotrophic lateral sclerosis: characterization of a large patient cohort.Diagnostic support for selected neuromuscular diseases using answer-pattern recognition and data mining techniques: a proof of concept multicenter prospective trial.Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net.Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis.Memory deficits in amyotrophic lateral sclerosis are not exclusively caused by executive dysfunction: a comparative neuropsychological study of amnestic mild cognitive impairmentStructural and functional hallmarks of amyotrophic lateral sclerosis progression in motor- and memory-related brain regions.Intracerebroventricular injection of encapsulated human mesenchymal cells producing glucagon-like peptide 1 prolongs survival in a mouse model of ALS.Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options.Working memory in ALS patients: preserved performance but marked changes in underlying neuronal networks.Cortical processing of swallowing in ALS patients with progressive dysphagia--a magnetoencephalographic study.Therapeutic potential of mesenchymal stromal cells and MSC conditioned medium in Amyotrophic Lateral Sclerosis (ALS)--in vitro evidence from primary motor neuron cultures, NSC-34 cells, astrocytes and microglia.Anti-ganglioside antibodies in amyotrophic lateral sclerosis revisitedNrf2/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALSThe Potential Role of Motor Unit Number Estimation as an Additional Diagnostic and Prognostic Value in Canine NeurologyExecutive Dysfunctions and Event-Related Brain Potentials in Patients with Amyotrophic Lateral SclerosisStructural and diffusion imaging versus clinical assessment to monitor amyotrophic lateral sclerosis.Working Memory Network Changes in ALS: An fMRI Study.Guidelines for preclinical animal research in ALS/MND: A consensus meeting.EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force.Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB-mediated pathogenic pathwaysAttenuated error-related potentials in amyotrophic lateral sclerosis with executive dysfunctions.The Axon Guidance Protein Semaphorin 3A Is Increased in the Motor Cortex of Patients With Amyotrophic Lateral Sclerosis.The concept and diagnostic criteria of primary lateral sclerosis.Widespread temporo-occipital lobe dysfunction in amyotrophic lateral sclerosis.FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study.Molecular and functional analyses of motor neurons generated from human cord-blood-derived induced pluripotent stem cells.4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced Pluripotent Stem Cells.Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience.Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial.Structural hallmarks of amyotrophic lateral sclerosis progression revealed by probabilistic fiber tractography.Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.Interhemispheric connectivity in amyotrophic lateral sclerosis: A near-infrared spectroscopy and diffusion tensor imaging study.Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study.Amyotrophic lateral sclerosis and novel therapeutic strategies.Magnetic resonance imaging in amyotrophic lateral sclerosis.Plekhg5-regulated autophagy of synaptic vesicles reveals a pathogenic mechanism in motoneuron disease.Oxidative stress in skeletal muscle stimulates early expression of Rad in a mouse model of amyotrophic lateral sclerosis.
P50
Q24623266-2E948EFD-8035-4A57-9986-97F5A44812E1Q28483618-1DE23DE0-9820-48B0-AA05-F9755828D7DCQ29114083-563B6F30-12FF-4BD4-B7EA-CEA5C8C8B45EQ30656923-EB186412-42C5-401F-A8B2-284598CC2ACCQ31055021-B3C6CC51-ACF0-429D-BEC9-ED6DDE8C61D7Q31141202-A0BB0A20-BC61-422B-A0EC-EA470FA12BC9Q33500473-C68B5D36-9DA1-4E9E-A332-DA006A5A6C32Q33863021-62A24416-7C9E-42C2-916D-3ABCBD833111Q34079265-B74497D7-4601-4535-917B-36ED80FE0BD1Q34321059-A7B99710-E612-4194-9AEE-572C215098B2Q34815254-EF1A3627-6360-4A45-8F26-C41B07B88388Q34950984-36D19EBB-D641-4D6D-8161-9B8BCBD565BBQ34995269-24A217D7-C441-4BDC-9170-F7EFD02C72F5Q34998538-84F7234B-77DB-4288-B989-F9041CC4669FQ35416888-0A985670-84CF-4E61-8240-11EE04849655Q36288479-E5151F99-B9B6-4BED-B4DB-7F7A9B466F8AQ36353420-6A1525DE-79DD-413B-8107-87898337474EQ36381707-17B80A60-DFB8-48CD-BD01-B16B9DFB83BFQ36787328-94F73A60-1924-467E-B23D-81B593C1A0B3Q36809236-917580F7-A9ED-497F-98E1-53CDE18FBF97Q37698628-766B9231-9322-4678-9ED8-FEC2BDA562F1Q37931374-0D7CC5F9-DE8D-4494-AEFE-253A07FD5BD4Q38330282-318AAE48-0A5B-4CEC-9BA0-040350F7338CQ38719112-117D7DD4-4EBE-4348-A99C-68ADC473753DQ38902666-69E6BCD1-0A49-4A4D-BD61-06A4F836E924Q39012146-5573C1F1-AEAC-45A0-A47B-05BAC8FC9122Q39032298-57300C54-551A-4789-A40C-C04BB1593FE8Q39041490-A8B86E6F-310F-4E9A-9325-7A3E3A41D9AEQ39162404-6DEE0469-C967-4BA6-B447-42D6554DE355Q39945217-531681CA-1849-4F7E-B9A3-AB6E9C7C8FA1Q40249258-9FBF6C61-654F-4FCD-8F93-CA959BA8CABEQ40358058-8CACA512-FEC4-42A6-AEB9-8EC0B48DED82Q40754037-87E8E8ED-228B-4CBA-88A7-6430B8E39F5DQ41392222-F547A2A4-65D6-49FB-9581-468764707F9FQ41466685-DB007DEF-CEB2-4A6F-9381-90698C3107B7Q41531607-158DE360-7576-4630-8DAA-07F829BADB05Q42075879-E69E70D7-0239-40EC-825D-CF1F727EE665Q42242501-C0411077-4ED7-4382-86A5-3EE1A7C12770Q42940640-83862865-327F-4155-B241-3A8B4F658BBBQ43192594-3069FF2C-4514-4AAD-9475-DBA588B2749C
P50
name
Susanne Petri
@ast
Susanne Petri
@en
Susanne Petri
@es
Susanne Petri
@nl
type
label
Susanne Petri
@ast
Susanne Petri
@en
Susanne Petri
@es
Susanne Petri
@nl
prefLabel
Susanne Petri
@ast
Susanne Petri
@en
Susanne Petri
@es
Susanne Petri
@nl